ImmunoCellular Therapeutics (IMUC) Trims Number of Shares in Expected Stock Offering

August 8, 2016 7:28 AM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

ImmunoCellular Therapeutics (NYSE: IMUC) filed Post-Effective Amendment No. 1 to its Registration Statement on Form S-1. In part, the filing said that the company plans to sell 45 million shares of its common stock, down from 51.5 million shares prior.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Corporate News, Equity Offerings

Related Entities

S1

Add Your Comment